Medicare spending for ‘accelerated approval’ drugs on the rise, study finds

Annual spending on drugs granted accelerated approval by the Food and Drug Administration increased significantly over the past half decade, a study published Friday by JAMA Health Forum found.

Share on FacebookEmail this to someoneShare on Google+Tweet about this on TwitterPrint this pageShare on LinkedInShare on StumbleUponShare on TumblrShare on RedditFlattr the authorPin on PinterestBuffer this pageDigg this